Mathieu Boulin

Title: The Innovative Contributions of Mathieu Boulin

Introduction

Mathieu Boulin is a notable inventor based in Dijon, France. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative approach has led to the development of a unique formulation that combines Lipiodol with anti-tumor agents.

Latest Patents

One of Mathieu Boulin's key patents is titled "Lipiodol-based anti-tumour emulsion for treating cancer." This invention relates to a pharmaceutical composition that includes Lipiodol and a molecule with anti-tumor activity, along with hydroxyethyl starch. The composition is designed for treating cancer and contains specific proportions of idarubicin, hydroxyethyl starch, and Lipiodol, ensuring effective delivery of the therapeutic agents.

Career Highlights

Throughout his career, Mathieu Boulin has worked with prominent companies in the pharmaceutical industry, including Guerbet and Chu De Dijon. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in cancer treatment.

Collaborations

Mathieu Boulin has collaborated with esteemed colleagues such as Boris Guiu and Jean-Pierre Cercueil. These partnerships have fostered a collaborative environment that enhances innovation and drives advancements in medical research.

Conclusion

Mathieu Boulin's contributions to the field of pharmaceuticals, particularly through his patent for a Lipiodol-based anti-tumor emulsion, highlight his commitment to improving cancer treatment. His work continues to inspire future innovations in the medical field.